Eli Lilly To Pay $45M To SC In Zyprexa Off-Label Deal
In the latest of a series of state settlements over Zyprexa, Eli Lilly & Co. has agreed to pay $45 million to South Carolina to resolve allegations it improperly marketed the...To view the full article, register now.
Already a subscriber? Click here to view full article